European Patent Office

T 0868/23 (CAR T-cells/2SEVENTY BIO) of 17.06.2025

European Case Law Identifier
ECLI:EP:BA:2025:T086823.20250617
Date of decision
17 June 2025
Case number
T 0868/23
Petition for review of
-
Application number
15783117.3
Language of proceedings
English
Distribution
No distribution (D)
OJ versions
No OJ links found
Other decisions for this case
-
Abstracts for this decision
-
Application title
Improved methods for manufacturing adoptive cell therapies
Applicant name
2seventy bio, Inc.
Opponent name
Dehns Limited
GlaxoSmithKline Intellectual Property
Development Limited
Boult Wade Tennant LLP
Board
3.3.08
Headnote
-
Relevant legal provisions
European Patent Convention Art 111(1)European Patent Convention Art 123(2)Rules of procedure of the Boards of Appeal Art 12(6)
Keywords
Main request and auxiliary requests 1 to 8 and 12 to 15 - added subject-matter - (yes)
Auxiliary requests 9 to 11 and 16 to 18 - should have been submitted in first-instance proceedings (yes)
Remittal to the department of first instance
Remittal - (no)
Catchword
-
Cited cases
-
Citing cases
-

Order

For these reasons it is decided that:

1. The decision under appeal is set aside.

2. The patent is revoked.